Date Filed | Type | Description |
05/31/2023 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Granted 3,812 shares
@ $0 Paid exercise price by delivering 242 shares
@ $194.12, valued at
$47k
Paid exercise price by delivering 132 shares
@ $194.12, valued at
$25.6k
Paid exercise price by delivering 216 shares
@ $194.12, valued at
$41.9k
Granted 9,145 options to buy
@ $194.12, valued at
$1.8M
|
|
03/08/2023 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Gifted 475 shares
@ $0 |
|
02/22/2023 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Paid exercise price by delivering 308 shares
@ $243.6, valued at
$75k
|
|
01/30/2023 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Granted 8,435 shares
@ $0 Paid exercise price by delivering 3,153 shares
@ $244.29, valued at
$770.2k
|
|
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2022 |
4
| Girshick Birgit (Corporate Executive VP & COO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Gifted 531 shares
@ $0 Granted 11,029 shares
@ $0 Paid exercise price by delivering 3,877 shares
@ $312.24, valued at
$1.2M
|
|
09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/21/2020 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Sold 933 shares
@ $213.51, valued at
$199.2k
|
|
06/02/2020 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Granted 1,948 shares
@ $0 Granted 6,500 options to buy
@ $179.66, valued at
$1.2M
|
|
05/13/2020 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Sold 780 shares
@ $165.74, valued at
$129.3k
|
|
02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/10/2019 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Sold 38 shares
@ $145.235, valued at
$5.5k
Sold 50 shares
@ $145.245, valued at
$7.3k
Sold 97 shares
@ $145.25, valued at
$14.1k
Sold 80 shares
@ $145.26, valued at
$11.6k
Sold 11 shares
@ $145.27, valued at
$1.6k
Sold 118 shares
@ $145.28, valued at
$17.1k
Sold 64 shares
@ $145.285, valued at
$9.3k
Sold 50 shares
@ $145.29, valued at
$7.3k
Sold 89 shares
@ $145.32, valued at
$12.9k
Sold 60 shares
@ $145.33, valued at
$8.7k
Sold 184 shares
@ $145.34, valued at
$26.7k
|
|
12/10/2019 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Sold 84 shares
@ $144.67, valued at
$12.2k
Sold 79 shares
@ $144.68, valued at
$11.4k
Sold 34 shares
@ $144.695, valued at
$4.9k
Sold 82 shares
@ $144.71, valued at
$11.9k
Sold 21 shares
@ $144.72, valued at
$3k
Sold 78 shares
@ $144.74, valued at
$11.3k
Sold 92 shares
@ $144.76, valued at
$13.3k
Sold 194 shares
@ $144.77, valued at
$28.1k
Sold 178 shares
@ $144.79, valued at
$25.8k
Sold 149 shares
@ $144.8, valued at
$21.6k
Sold 89 shares
@ $144.83, valued at
$12.9k
|
|
12/10/2019 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Sold 87 shares
@ $143.7, valued at
$12.5k
Sold 96 shares
@ $143.73, valued at
$13.8k
Sold 99 shares
@ $143.79, valued at
$14.2k
Sold 95 shares
@ $143.855, valued at
$13.7k
Sold 82 shares
@ $143.895, valued at
$11.8k
Sold 69 shares
@ $143.905, valued at
$9.9k
Sold 78 shares
@ $143.93, valued at
$11.2k
Sold 94 shares
@ $143.935, valued at
$13.5k
Sold 68 shares
@ $143.95, valued at
$9.8k
Sold 82 shares
@ $143.96, valued at
$11.8k
Sold 138 shares
@ $144.035, valued at
$19.9k
|
|
11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/28/2019 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC
Txns:
| Paid exercise price by delivering 152 shares
@ $145.31, valued at
$22.1k
Paid exercise price by delivering 125 shares
@ $140.71, valued at
$17.6k
|
|
02/26/2019 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC
Txns:
| Granted 2,775 shares
@ $0 Paid exercise price by delivering 316 shares
@ $144.67, valued at
$45.7k
Paid exercise price by delivering 322 shares
@ $144.67, valued at
$46.6k
Granted 11,832 options to buy
@ $144.67, valued at
$1.7M
|
|
02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2018 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC
Txns:
| Sold 3,978 shares
@ $119.9, valued at
$477k
|
|
03/07/2018 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC
Txns:
| Sold 1,500 shares
@ $109, valued at
$163.5k
Sold 200 shares
@ $109.02, valued at
$21.8k
Sold 100 shares
@ $109.04, valued at
$10.9k
Sold 100 shares
@ $109.05, valued at
$10.9k
Sold 190 shares
@ $109.055, valued at
$20.7k
Sold 400 shares
@ $109.06, valued at
$43.6k
Sold 543 shares
@ $109.07, valued at
$59.2k
Sold 300 shares
@ $109.075, valued at
$32.7k
Sold 200 shares
@ $109.08, valued at
$21.8k
Sold 10 shares
@ $109.085, valued at
$1.1k
Sold 650 shares
@ $109.09, valued at
$70.9k
|
|
03/01/2018 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC
Txns:
| Paid exercise price by delivering 67 shares
@ $107.82, valued at
$7.2k
|
|
02/28/2018 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC
Txns:
| Paid exercise price by delivering 83 shares
@ $108.95, valued at
$9k
|
|
02/26/2018 |
4
| Girshick Birgit (Corporate Executive VP) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC
Txns:
| Granted 2,840 shares
@ $0 Paid exercise price by delivering 214 shares
@ $109.34, valued at
$23.4k
Paid exercise price by delivering 101 shares
@ $109.34, valued at
$11k
Granted 12,818 options to buy
@ $109.34, valued at
$1.4M
|
|
02/21/2018 |
3
| Girshick Birgit (Corporate Executive VP) has filed a Form 3 on CHARLES RIVER LABORATORIES INTERNATIONAL INC |